TCL Archive ‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’ September 20, 1991
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel November 26, 1999
TCL Archive Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications March 18, 1977